The presence of an SNP in the ACAC‐B gene is associated to type 2 diabetic nephropathy susceptibility (T2DN) and it seems that targeting this pathway could be a potential therapy approach for diabetic nephropathy prevention (Tang et al., 2010). The gene discussed is ACACB; the disease is type 2 diabetes nephropathy.